Good science doesn't guarantee good drugs.
Siegel
J
J
Mabon Securities, New York, USA.
D001709:Biotechnology; D015195:Drug Design; D004345:Drug Industry; D004358:Drug Therapy; D005818:Genetic Engineering; D006801:Humans; D015202:Protein Engineering; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins